CINECA IRIS Institutional Research Information System

MICCOLI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.333
AS - Asia 9.220
EU - Europa 7.259
SA - Sud America 1.152
AF - Africa 331
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 9
Totale 36.333
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.715
SG - Singapore 2.848
CN - Cina 2.801
IT - Italia 2.608
HK - Hong Kong 1.372
SE - Svezia 1.128
BR - Brasile 947
BG - Bulgaria 633
VN - Vietnam 607
DE - Germania 552
CA - Canada 511
GB - Regno Unito 463
TR - Turchia 410
KR - Corea 397
UA - Ucraina 389
FI - Finlandia 346
FR - Francia 343
RU - Federazione Russa 284
IN - India 203
CH - Svizzera 171
JP - Giappone 105
AT - Austria 102
BD - Bangladesh 92
CI - Costa d'Avorio 84
AR - Argentina 73
IQ - Iraq 63
NL - Olanda 52
BE - Belgio 47
SN - Senegal 46
SA - Arabia Saudita 43
MX - Messico 41
PK - Pakistan 40
NG - Nigeria 39
ZA - Sudafrica 37
VE - Venezuela 30
EG - Egitto 26
EC - Ecuador 25
PL - Polonia 24
MA - Marocco 23
CO - Colombia 22
ID - Indonesia 21
JO - Giordania 21
TN - Tunisia 20
UZ - Uzbekistan 20
AU - Australia 19
ES - Italia 18
IE - Irlanda 18
KE - Kenya 17
MY - Malesia 17
PE - Perù 17
IR - Iran 16
AE - Emirati Arabi Uniti 15
IL - Israele 15
JM - Giamaica 14
UY - Uruguay 14
KZ - Kazakistan 13
NP - Nepal 12
PH - Filippine 12
CL - Cile 11
TT - Trinidad e Tobago 11
OM - Oman 10
CZ - Repubblica Ceca 9
NZ - Nuova Zelanda 9
PT - Portogallo 9
BO - Bolivia 8
DK - Danimarca 8
DO - Repubblica Dominicana 8
LT - Lituania 8
AZ - Azerbaigian 7
BJ - Benin 7
GR - Grecia 7
PA - Panama 7
RO - Romania 7
DZ - Algeria 6
HU - Ungheria 6
BB - Barbados 5
LB - Libano 5
SY - Repubblica araba siriana 5
TH - Thailandia 5
TW - Taiwan 5
AM - Armenia 4
AO - Angola 4
BY - Bielorussia 4
ET - Etiopia 4
GE - Georgia 4
HR - Croazia 4
KG - Kirghizistan 4
LK - Sri Lanka 4
QA - Qatar 4
XK - ???statistics.table.value.countryCode.XK??? 4
CR - Costa Rica 3
EU - Europa 3
LA - Repubblica Popolare Democratica del Laos 3
LC - Santa Lucia 3
NI - Nicaragua 3
NO - Norvegia 3
PS - Palestinian Territory 3
PY - Paraguay 3
AL - Albania 2
BH - Bahrain 2
Totale 36.272
Salva come PNG Salva come JPEG
Città #
Ashburn 1.782
Woodbridge 1.767
Singapore 1.655
Ann Arbor 1.536
Hong Kong 1.354
Fairfield 1.254
Chandler 1.205
Houston 1.159
Milan 876
San Jose 843
Santa Clara 842
Dallas 746
Sofia 629
Hefei 595
Seattle 580
Beijing 532
Jacksonville 526
Wilmington 457
Shanghai 449
Ottawa 435
New York 401
Cambridge 396
Seoul 394
Boardman 291
Princeton 266
Lawrence 239
Izmir 238
Lauterbourg 208
Nanjing 207
Medford 200
Los Angeles 191
Des Moines 177
Bern 165
Serra 163
Dearborn 147
Istanbul 138
Rome 134
Ho Chi Minh City 119
Buffalo 105
Dong Ket 97
Tokyo 92
Hanoi 90
Jüchen 90
Florence 88
Abidjan 84
Vienna 79
Nanchang 78
Frankfurt am Main 75
San Diego 70
The Dalles 67
Columbus 63
Falls Church 63
Pisa 63
Redondo Beach 63
Helsinki 60
London 60
Council Bluffs 58
São Paulo 58
Boulder 54
Redwood City 54
Marseille 49
Kunming 47
Lancaster 47
Tianjin 47
Brussels 46
Dakar 46
Manchester 46
Bremen 42
Munich 38
Pune 38
Chennai 36
Lagos 36
Shenyang 36
Nuremberg 35
Changsha 34
Jiaxing 34
Rio de Janeiro 33
Hebei 32
Orem 31
Verona 31
Baghdad 28
San Francisco 28
Naples 27
Ogden 26
Fuzhou 25
Phoenix 25
Dhaka 23
Da Nang 22
Norwalk 22
Washington 22
Brasília 21
Amman 20
Belo Horizonte 20
Chicago 20
Hangzhou 20
Lanzhou 20
Orange 20
Turku 20
Warsaw 20
Auburn Hills 19
Totale 26.139
Salva come PNG Salva come JPEG
Nome #
UN INSOLITO CASO DI IPOGLICEMIA IPERINSULINEMICA DA NESIDIOBLASTOSI E INSULINOMA 804
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 288
Lipoprotein Glomerulopathy: Molecular Characterization of Three Italian Patients and Literature Survey 268
Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus 249
Prevalence and risk factors for gestational diabetes assessed by universal screening 220
National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants 219
Early detection of left ventricular dysfunction in diabetes mellitus patients with normal ejection fraction, stratified by BMI: A preliminary speckle tracking echocardiography study 208
Microvascular complications burden (nephropathy, retinopathy and peripheral polyneuropathy) affects risk of major vascular events and all-cause mortality in type 1 diabetes: A 10-year follow-up study 208
Valutazione dell'asse ipotalamo-ipofisi-gonadi nel maschio diabetico. 207
Short-term vs. overnight urine collection for screening of urinary albumin excretion rate. 207
CLINICAL AND METABOLIC EFFECTS OF A PILL CONTAINING 30 MCG ETHINYLESTRADIOL PLUS 75 MCG GESTODENE 204
Albuminuric and non-albuminuric chronic kidney disease in type 1 diabetes: Association with major vascular outcomes risk and all-cause mortality 203
PPARG2 Pro12Ala and ADAMTS9 rs4607103 as "insulin resistance loci" and "insulin secretion loci" in Italian individuals. The GENFIEV study and the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 4 198
Optimizing management of metabolic syndrome to reduce the risk: focus on life-style 197
Circulating Endothelial Cells (EPC) and Endothelium-derived Microparticles (EdMPs) time-course throughout the natural history of type 2 diabetes 196
Protein intake and urinary albumin excretion rates in the EURODIAB IDDM complications study 195
Nutritional intake of 2868 IDDM patients from 30 centres in Europe 195
Microvascular and acute complications in insulin dependent diabetes mellitus: the EURODIAB IDDM Complications Study 194
THE RELATIONSHIP BETWEEN SMOKING AND MICROVASCULAR COMPLICATIONS IN THE EURODIAB IDDM COMPLICATIONS STUDY 192
Dietary saturated fat and fibre and risk of cardiovascular disease and all-cause mortality among type 1 diabetic patients:the EURODIAB Prospective Complications Study 190
Serum gamma-glutamyltransferase levels are related to insulin sensitivity and secretion in subjects with abnormal glucose regulation 190
Optimal therapy of type 2 diabetes: a controversial challenge 190
Relationship between total cholesterol level and impairment of intrinsic myocardial contractility, strain and of the active phase of relaxation EUROPEAN HEART JOURNAL AUG 2006 VL 27 SU Suppl. 1 BP 405 EP 406 187
Cardiovascular disease and its risk factors in IDDM in Europe 187
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: A comparative risk assessment 187
Normoalbuminuric chronic kidney disease in type 1 diabetes: is it real and is it serious? Reply to Rigalleau V, Blanco L, Alexandre L et al [letter] 187
PRAVASTATIN VS GEMFIBROZIL IN THE TREATMENT OF PRIMARY HYPERCHOLESTEROLEMIA - THE ITALIAN MULTICENTER PRAVASTATIN STUDY-I 185
EFFECTS OF PANTETHINE ON LIPIDS AND APOLIPOPROTEINS IN HYPERCHOLESTEROLEMIC DIABETIC AND NON DIABETIC-PATIENTS 184
MICROALBUMINURIA IN TYPE-I (INSULIN-DEPENDENT) DIABETIC-PATIENTS WITH AND WITHOUT RETINOPATHY 184
An optimized method to measure glycosylproteins: HPLC assay of 5-hydroxymethil-2-furfuraldehyde (5-HMF). 183
Interaction of DIO2 T92A and PPARgamma2 P12A polymorphisms in the modulation of metabolic syndrome 183
Diabetes programme facts and figures 183
QTc interval prolongation is independently associated with severe hypoglycemic attacks in type 1 diabetes from the EURODIAB IDDM complications study. 183
Basal insulin kinetics and glucose-stimulated secretion in untreated and treated diabetic patients and in normal subjects. 182
Enzimuria e tubulopatia diabetica: più di un semplice sospetto. 182
PREVALENCE AND TYPE OF SEXUAL DYSFUNCTIONS IN DIABETIC MALES - A STANDARDIZED CLINICAL APPROACH 182
Genetically determined absence of HDL-cholesterol and coronary atherosclerosis 182
Metabolic syndrome and vascular alterations in normotensive subjects at risk of diabetes mellitus 182
CLINICAL AND METABOLIC STUDY OF A NEW PILL CONTAINING 20 MCG ETHINYLESTRADIOL PLUS 0.150 MG DESOGESTREL 181
C-reactive protein and metabolic syndrome in women with previous gestational diabetes 181
Influence of high density lipoprotein cholesterol levels on circulating monocytic angiogenic cells functions in individuals with type 2 diabetes mellitus 181
Impaired brain plasticity in obesity: effects of bariatric surgery and gut hormones 181
Diabete e disturbi dell'attivita' sessuale 180
Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study 180
Valutazione del grado di conoscenza basale della malattia diabetica in pazienti ambulatoriali. 178
Relationship between plasma sialic acid and fibrinogen concentration and incident micro- and macrovascular complications in type 1 diabetes. The Eurodiab Prospective Complications Study(PCS) 178
Circulating lipid levels and severity of diabetic retinopathy in type I diabetes mellitus. 177
Which method for 'microalbuminuria' in diabetes mellitus? 176
Recurrent mutations of the apolipoprotein A-I gene in three kindreds with severe HDL deficiency 176
Diabete ed educazione: ruolo ed utilità clinica dell'educazione formale 175
Dietary habits in type 2 diabetes mellitus: how is adherence to dietary recommendations? 175
Pathogenetic mechanisms and cardiovascular risk: differences between HbA(1c) and oral glucose tolerance test for the diagnosis of glucose tolerance 175
Prognostic implications of diabetes phenotyping: new concepts for an old disease 175
Metabolic regulation of GLP-1 and PC1/3 in pancreatic α-cell line 175
Feasibility and effectiveness in clinical practice of a multifactorial intervention for the reduction of cardiovascular risk in patients with type 2 diabetes: the 2-year interim analysis of the MIND.IT study: a cluster randomized trial 174
SIRT1 rs7896005 polymorphism may be related to coronary artery disease in Caucasians with type 2 diabetes, without affecting all-cause mortality. 174
Repeatability of three-day dietary records in the EURODIAB IDDM complications study 172
Insulin Resistance and Lipid Disorders 172
Metabolic syndrome in subjects at high risk for type 2 diabetes: The genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study 172
Left ventricular dysfunction in normotensive young adult patients with well-controlled type-I diabetes EUROPEAN HEART JOURNAL AUG 2006 VL 27 SU Suppl. 1 BP 535 EP 535 171
Intermediate metabolism in normal pregnancy and in gestational diabetes 171
BLOOD-PRESSURE, RETINOPATHY AND URINARY ALBUMIN EXCRETION IN IDDM - THE EURODIAB IDDM COMPLICATIONS STUDY 170
Basal insulin and cardiovascular and other outcomes in dysglycemia 170
Metabolic control affects plasma lipid and apolipoprotein levels in women, but not in men, with IDDM 168
A natural apolipoprotein A-I variant, apoA-I(L141R)(Pisa), interferes with the formation of alpha-high density lipoproteins (HDL) but not with the formation of pre beta(1)-HDL and influences efflux of cholesterol into plasma 167
Endothelial progenitor cells and endothelial dysfunction in prediabetic and newly diagnosed type 2 diabetic subjects 166
Influence of severe obesity on circulating endothelial progenitor cells levels and effects of bariatric surgery 166
Unhealthy dietary patterns associated with inflammation and endothelial dysfunction in type 1 diabetes: The EURODIAB study 165
Diabetic ketoacidosis and acute pancreatitis associated with antipsychotic drugs: report of a case 165
Human EPCs and HUVECs exposed to high glucose: expression of antioxidative enzymes 163
Effects of guar-pasta on serum lipid levels in obese diabetic and non-diabetic women with normal lipids. 163
Circulating endothelial progenitor cells (EPCs) in subjects with impaired glucose regulation (Pre-Diabetes) 162
Is there evidence that oral hypoglycemic agents reduce cardiovascular morbidity/mortality? Yes 162
Factitious hypoglycemia in an insulin-dependent woman in the eighth week of gestation 162
Radiofrequency-based estimates of local common carotid stiffness and intima-media thickness: implications for detecting early vascular involvement in hypertension and diabetes 160
Divergent changes in expression of antioxidant enzymes in human EPCs and HUVECs exposed to high glucose 159
Primary Prevention of Cardiovascular Disease in People With Dysglycemia 159
Guar-pasta: a new diet for obese subjects? 159
Compound heterozygosity for a structural apolipoprotein A-I variant, apo A-I(L141R)(Pisa), and an apolipoprotein A-I null allele in patients with absence of HDL, cholesterol, corneal opacifications, and coronary heart disease 159
Fibrinogen and von Willebrand factor in IDDM: Relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: The EURODIAB IDDM complications study 158
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial. 158
Insulin degludec/insulin aspart combination for the treatment of type 1 and type 2 diabetes 158
'Microalbuminuria' in type I (insulin-dependent) diabetic patients with and without retinopathy. 157
Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance 157
Hyperglycaemia and cardiovascular risk 157
Probiotic Lisosan G preserves functional properties of human endo- thelial progenitor cells exposed to lipopolysaccharides 157
Association between a metabolic syndrome severity score and all- cause mortality in type 1 diabetes: a 10-year follow-up study 157
EFFECTS OF LOW-DOSES OF TIADENOLO IN DIABETIC AND NON-DIABETIC PATIENTS WITH VARIOUS TYPES OF HYPERLIPOPROTEINEMIAS 156
The EURODIAB IDDM Complications Study Group. Prevalence of Q-T Interval Dispersion in Type 1 Diabetes and Its Relation With Cardiac Ischemia 155
The Metabolic Syndrome 153
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 153
Prevalence of the metabolic syndrome among Italian adults according to ATP III definition 153
Albuminuria estimated from proteinuria in diabetics. Is it a real alternative in clinical practice? 152
Effects of tiadenolo on hypercholesterolemic diabetic and non-diabetic patients. 152
Microalbuminuria is linked with abnormalities favoring atherosclerosis in type 2 diabetics. 152
Insulin resistance and risk of major vascular events and all-cause mortality in type 1 diabetes: A 10-year follow-up study 151
Relation between microalbuminuria and diabetic retinopathy. 150
Risposta del GH al GHRH, alla clonidina ed al TRH nel diabete mellito tipo I. 150
Endothelial progenitor cells in subjects with pre-diabetes 150
Uremia e disturbi dell'attivita' sessuale 149
Totale 18.395
Salva come PNG Salva come JPEG
Categoria #
all - tutte 99.454
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.454
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021308 0 0 0 0 0 0 0 0 0 0 0 308
2021/20222.724 26 171 53 178 563 361 77 130 153 74 161 777
2022/20233.310 447 383 181 325 402 466 45 257 515 20 222 47
2023/20242.917 463 318 405 208 440 468 77 112 61 70 77 218
2024/20257.544 42 311 162 465 634 695 536 419 666 943 930 1.741
2025/20267.472 591 1.122 1.006 593 656 729 1.256 297 325 595 214 88
Totale 36.602